Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Chemodex
4-Hydroxytamoxifen solution (5 mg/ml in ethanol:isopropanol (95:5))
As low as
CHF 155.00
In stock
Only %1 left
CDX-H0471-L0011 mlCHF 155.00
Specifications / Handling
| Product Details | |
|---|---|
| Synonyms | Afimoxifene; 4-OHT; cis/trans-4-Hydroxytamoxifen; (E/Z)-4-Hydroxytamoxifen; HTMX; 4-(1-[4-(Dimethylaminoethoxy)phenyl]-2-phenyl-1-butenyl)phenol |
| Product Type | Chemical |
| Properties | |
| Formula | C26H29NO2 |
| MW | 387.51 |
| CAS | 68392-35-8 (comp.) |
| RTECS | SL1210000 |
| Source/Host Chemicals | Synthetic |
| Purity Chemicals | ≥98% (HPLC) |
| Appearance | Colourless liquid. 5 mg/mL in ethanol:isopropanol (95:5). |
| Solubility | Soluble in ethanol. |
| Identity | Determined by 1H-NMR. |
| Declaration | Manufactured by Chemodex. |
| Other Product Data |
Click here for Original Manufacturer Product Datasheet |
| InChi Key | TXUZVZSFRXZGTL-QPLCGJKRSA-N |
| Smiles | CC/C(C1=CC=CC=C1)=C(C2=CC=C(O)C=C2)/C3=CC=C(OCCN(C)C)C=C3 |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice | Protect from light and moisture. |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Scientific Background Information
Product Description
4-Hydroxytamoxifen is an active metabolite of the chemotherapeutic drug tamoxifen, a selective estrogen receptor modulator (SERM) that acts as an agonist or antagonist in various tissues. 4-Hydroxytamoxifen acts as a tissue-selective agonist-antagonist of the estrogen receptors ERα and ERβ. 4-Hydroxytamoxifen is an isoform-specific inhibitor of orphan estrogen-receptor-related (ERR) nuclear receptors β and γ. 4-Hydroxytamoxifen exhibits anticancer chemotherapeutic activity, inducing autophagy and vacuole formation as well as KRAS degradation in various cancer cell lines. In cardiac myocytes, 4-hydroxytamoxifen decreases Ca2+ amplitude, slowing relaxation and decreasing contractility. 4-Hydroxytamoxifen has also shown to be a potent inhibitor of the mitochondrial permeability transition (MPT).
Product-specific References
[1] N. Terakawa, et al.; Cancer 61, 1312 (1988) | [2] H. Wiseman, et al.; FEBS Lett. 274, 107 (1990) | [3] G. Freiss, et al.; BBRC 173, 919 (1990) | [4] H. Wiseman, et al.; Biochem J. 292, 635 (1993) | [5] A.M. Davies, et al.; Biochem. Soc. Trans. 23, 439S (1995) | [6] S.T. Willard, et al.; Endocrine 14, 247 (2001) | [7] P. Coward, et al.; PNAS 98, 8880 (2001) | [8] G.B. Tremblay, et al.; Endocrinology 142, 4572 (2001) | [9] H.K. Crewe, et al.; Drug Metab. Dispos. 30, 869 (2002) | [10] C.M. Cardoso, et al.; Mitochondrion 1, 485 (2002) | [11] J.P. Monteiro, et al.; Toxicol. In Vitro 17, 629 (2003) | [12] Z. Desta, et al.; J. Pharmacol. Exp. Ther. 310, 1062 (2004) | [13] H. Seeger, et al.; Horm. Metab. Res. 36, 277 (2004) | [14] E.A. Ariazi & V.C. Jordan; Curr. Top. Med. Chem. 6, 203 (2006) (Review) | [15] M.L. Asp, et al.; PLoS One 8, e78768 (2013) | [16] L. Kohli, et al.; Cancer Res. 73, 4395 (2013) | [17] L. Duan, et al.; Cancer Lett. 353, 290 (2014)
You're in the Switzerland store. Not in Switzerland? Choose your country
You're in the Switzerland store (prices in CHF, shipping to Switzerland only). Ordering from another country? Please select it below.
Please note that not all products are available in every country store. Choose your country before starting the ordering process.
Country
Switzerland
United Kingdom
France
Germany
Austria
Italy
South Korea
United States
Argentina
Australia
Belgium
Bosnia and Herzegovina
Brazil
Canada
Chile
China
Colombia
Cyprus
Czech Republic
Denmark
Ecuador
Egypt
Estonia
Finland
Greece
Hong Kong
Hungary
India
Iran
Iraq
Ireland
Israel
Japan
Latvia
Lithuania
Luxembourg
Malaysia
Mexico
Netherlands
New Zealand
Norway
Pakistan
Peru
Poland
Portugal
Romania
Russia
Singapore
Slovakia
Slovenia
South Africa
Spain
Sweden
Syria
Taiwan
Thailand
Turkey
Uruguay
Venezuela
Other Country
No country found




Download PDF